NRXP NRx Pharmaceuticals, Inc.
Healthcare$4.18+0.00%OpenMarket Cap: $72.3M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$2.00
Target (Median)
$2.00
Target Range
$2.00 - $2.00
Upside from current price: -52.2%
Rating Distribution
0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-05 | D. Boral Capital | maintain | Buy | Buy |
| 2026-04-27 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-27 | Ascendiant Capital | maintain | Buy | Buy |
| 2026-03-24 | BTIG | maintain | Buy | Buy |
| 2026-03-24 | D. Boral Capital | maintain | Buy | Buy |
| 2026-03-03 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-18 | BTIG | maintain | Buy | Buy |
| 2026-02-17 | D. Boral Capital | maintain | Buy | Buy |
| 2026-01-15 | BTIG | maintain | Buy | Buy |
| 2026-01-05 | D. Boral Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $0.69 | $112.8M | 2 |
| Fri Dec 31 | $1.97 | $301.7M | 2 |
| Sun Dec 31 | $8.42 | $732.0M | 2 |
| Mon Dec 31 | $15.42 | $1.28B | 1 |